TickerFacts.

Harmony Biosciences Holdings, Inc. (HRMY): Operating Income

Annual figures by period end, from SEC filings.

$208.47M
Year ended 2025-12-31
$230.65M
Trailing 12 months to 2026-06-30
+20.2%
3-year compound annual growth
+65.1%
5-year compound annual growth
2019-12-31: -$145.90M2020-12-31: $16.99M2021-12-31: $87.53M2022-12-31: $120.19M2023-12-31: $192.03M2024-12-31: $190.83M2025-12-31: $208.47M$208.47M
2019-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$208.47M+9.2%2026-02-24, From 2025-01-01
2024-12-31$190.83M-0.6%2026-02-24, From 2024-01-01
2023-12-31$192.03M+59.8%2026-02-24, From 2023-01-01
2022-12-31$120.19M+37.3%2025-02-25, From 2022-01-01
2021-12-31$87.53M+415.3%2024-02-22, From 2021-01-01
2020-12-31$16.99Mn/m2023-02-21, From 2020-01-01
2019-12-31-$145.90Mn/a2022-02-28, From 2019-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Harmony Biosciences Holdings, Inc. (HRMY)2025-12-31$208.47M+9.2%
ANI Pharmaceuticals Inc (ANIP)2025-12-31$111.09Mn/m
Arrowhead Pharmaceuticals, Inc. (ARWR)2025-09-30$98.35Mn/m
Ionis Pharmaceuticals Inc (IONS)2025-12-31-$381.68Mn/m
Madrigal Pharmaceuticals, Inc. (MDGL)2025-12-31-$300.10Mn/m
Collegium Pharmaceutical, Inc (COLL)2025-12-31$179.64M+5.7%
Corcept Therapeutics Inc (CORT)2025-12-31$44.80M-67.3%
Emergent BioSolutions Inc. (EBS)2025-12-31$100.10Mn/m
Pacira BioSciences, Inc. (PCRX)2025-12-31$19.19Mn/m

Compare HRMY, ANIP, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗